Package 70518-4340-0

{"route": ["ORAL"], "spl_id": "3ba02ab7-e19a-6da4-e063-6394a90af058", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["3f99b26b-79b9-4efb-aa2c-2868e1e126c8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "100 POUCH in 1 BOX (70518-4340-0)  / 1 TABLET, FILM COATED in 1 POUCH (70518-4340-1)", "package_ndc": "70518-4340-0", "marketing_start_date": "20250515"}, {"sample": false, "description": "30 POUCH in 1 BOX (70518-4340-2)  / 1 TABLET, FILM COATED in 1 POUCH (70518-4340-3)", "package_ndc": "70518-4340-2", "marketing_start_date": "20250609"}], "brand_name": "Topiramate", "product_id": "70518-4340_3ba02ab7-e19a-6da4-e063-6394a90af058", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-4340", "generic_name": "Topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA077627", "marketing_category": "ANDA", "marketing_start_date": "20250515", "listing_expiration_date": "20261231"}